
Ryanair notched up the first wins in its campaign to topple billions of euros of COVID-19 bailouts for rival carriers after European Union judges faulted EU regulators for failing to properly check whether aid was justified, reported Bloomberg.
The EU General Court, the bloc’s second-highest tribunal, on Wednesday, May 19, overturned the European Commission’s approval of a €3.4 billion (US$4.2 billion) Dutch subsidy to Air France-KLM and €1.2 billion offered by Portugal to TAP SGPS.
But rather than order the repayment of subsidies, judges gave regulators the chance to re-examine the cases and fix any procedural flaws. Ryanair on Wednesday lost a separate challenge to a €10 billion Spanish fund for local carriers.
Ryanair has filed more than two dozen challenges to EU approvals for pandemic aid doled out by governments to carriers, including Deutsche Lufthansa AG and Air France-KLM. The Irish low-cost carrier, which has lost five of the challenges so far, argued that the aid for selected airlines creates an unfair advantage and will help rivals to emerge stronger, slash fares, and swallow up others.
Ryanair said in a statement that the two rulings in its favor were “an important victory for consumers and competition,” calling the EU’s aid approvals “discriminatory,” risking distortion to markets “for decades to come.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas